142 results on '"Young, Neal S."'
Search Results
2. Alemtuzumab in relapsed immune severe aplastic anemia: Long‐term results of a phase II study.
3. S176: FUNCTIONAL AND ANTIGEN‐SPECIFIC CHARACTERIZATION OF IMMUNE CELLS AT THE SINGLE‐CELL LEVEL REVEALS CONVERGENCE OF ADAPTIVE AND INNATE IMMUNITY IN IMMUNE APLASTIC ANEMIA.
4. Long‐term eltrombopag for bone marrow failure depletes iron.
5. Conditional deletion of mTOR discloses its essential role in early B‐cell development.
6. Acquired Aplastic Anaemia
7. COVID‐19 infection in patients with severe aplastic anaemia.
8. Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia.
9. Deficit of circulating CD19+CD24hiCD38hi regulatory B cells in severe aplastic anaemia.
10. Attenuation of immune‐mediated bone marrow damage in conventionally housed mice.
11. Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.
12. Optimization and standardization of fluorescent cell barcoding for multiplexed flow cytometric phenotyping.
13. Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes.
14. Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.
15. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/ MDS.
16. Telomere content measurement in human hematopoietic cells: Comparative analysis of qPCR and Flow-FISH techniques.
17. Towards treatments for VEXAS.
18. Peromyscus leucopus mice: a potential animal model for haematological studies.
19. Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.
20. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.
21. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6p LOH in GPI (+) but not in GPI (−) granulocytes.
22. Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
23. Myelodysplasia in the setting of paroxysmal nocturnal hemoglobinuria: Interpretation of blast percentage in a marrow with erythroid hyperplasia.
24. Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.
25. Dyskeratosis congenita: The first NIH clinical research workshop.
26. Expansion of haematopoietic stem cells from normal donors and bone marrow failure patients by recombinant hoxb4.
27. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia.
28. Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.
29. Cytokine gene polymorphisms in acquired bone marrow failure.
30. Decreased TCR ζ-chain expression in T cells from patients with acquired aplastic anaemia.
31. Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients.
32. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
33. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.
34. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
35. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria.
36. research paper Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability.
37. Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes.
38. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders.
39. Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive.
40. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.
41. A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
42. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
43. Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back.
44. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features.
45. Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.
46. Regional patterns in the incidence of aplastic anemia in Thailand.
47. Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells.
48. Antithymocyte globulin for patients with myelodysplastic syndrome.
49. Prevalence of GBV-C/HGV, a novel 'hepatitis' virus, in patients with aplastic anaemia.
50. Expression and modulation of cellular receptors for interferon-γ, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.